Characterization of Foveal Development in Treatment-Naïve Extremely Preterm Infants.
Journal
Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
16
6
2022
Statut:
ppublish
Résumé
To characterize and quantify foveal development in treatment-naïve extremely preterm infants using optical coherence tomography. In this cross-sectional study, eyes treated for retinopathy of prematurity before imaging were excluded. Inner retinal thickness and outer retina thickness at foveal center and foveal rim were assessed. Extremely preterm (EPT, <28 weeks gestational age) eyes were compared with infants more than 28 weeks of gestation using a multivariable dimension reduction analysis (principal component analysis) and a bilinear factor mode analysis (partial least square discriminant analysis) to determine group intervariability. Further analyses were performed to investigate the effects of gestation on foveal development. Twenty-six infants born at gestational ages ranging from 22 to 39 weeks were imaged between 32 and 80 weeks postmenstrual age. A principal component analysis and partial least squares discriminant analysis revealed that the foveal inner retina thickness was the main difference between EPT infants and non-EPT infants. This difference was reflected by comparing their inner retinal thickness over time (32-80 weeks postmenstrual age), which revealed a sustained thicker foveal inner retina for EPT infants when compared with non-EPT infants. The foveal pit seemed to be shallower in EPT infants when compared with non-EPT infants. Twenty-eight weeks of gestation seems to be a critical timepoint for foveal development; EPT infants had altered foveal inner retinal development throughout early postnatal development, which led to a thicker foveal inner retina and a shallower foveal pit soon after birth. Measuring untreated foveal parameters informs about the effects of prematurity on the fovea and provides a baseline when comparing with post-treatment foveal development.
Identifiants
pubmed: 35696134
pii: 2782972
doi: 10.1167/tvst.11.6.11
pmc: PMC9202331
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11Références
Arch Ophthalmol. 2005 Jul;123(7):991-9
pubmed: 16009843
Lancet Glob Health. 2019 Aug;7(8):e1130-e1138
pubmed: 31303299
Invest Ophthalmol Vis Sci. 2021 Jul 1;62(9):23
pubmed: 34269816
Prog Retin Eye Res. 2018 Sep;66:49-84
pubmed: 29609042
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):4948-4958
pubmed: 28973368
Vision Res. 1986;26(6):847-55
pubmed: 3750868
Retina. 2020 Aug;40(8):1592-1602
pubmed: 31356497
Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):908-13
pubmed: 25587063
Am J Ophthalmol Case Rep. 2020 Feb 24;18:100624
pubmed: 32154434
Eye (Lond). 2019 Dec;33(12):1890-1896
pubmed: 31273311
Anesth Analg. 2015 Jun;120(6):1337-51
pubmed: 25988638
Retina. 2020 Jul;40(7):1344-1352
pubmed: 31157715
BMC Genomics. 2006 Jun 08;7:142
pubmed: 16762068
Int J Gynaecol Obstet. 2020 Jul;150(1):31-33
pubmed: 32524596
Lancet. 2013 Oct 26;382(9902):1445-57
pubmed: 23782686
Ophthalmol Retina. 2021 Jun;5(6):580-592
pubmed: 32927150
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):25
pubmed: 33599735
Am J Ophthalmol. 2012 Nov;154(5):779-789.e2
pubmed: 22898189
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):28
pubmed: 32936301
Am J Ophthalmol. 2020 Nov;219:177-185
pubmed: 32569738
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Am J Ophthalmol. 2012 Nov;154(5):767-778.e2
pubmed: 22935600
Retina. 2019 Nov;39(11):2233-2239
pubmed: 30180146
Ophthalmology. 2011 Dec;118(12):2315-25
pubmed: 21940051
Ophthalmology. 2019 Jan;126(1):107-112
pubmed: 30092239
Eye (Lond). 2020 Jun;34(6):1077-1085
pubmed: 31645674
Ophthalmology. 2018 Mar;125(3):444-452
pubmed: 29103792
Bioinformatics. 2002;18 Suppl 1:S105-10
pubmed: 12169537